Rodgers Dermatology

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Apollo Therapeutics Ltd1 trial
• Insmed Incorporated1 trial

Closed trials

• Completed

  A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

  NCT06436183· Phase 2· Apollo Therapeutics Ltd· Source

• Completed

  Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)

  NCT06101823· Phase 2· Insmed Incorporated· Source